← Back to Search

Evidence Impact on Biologics Confidence for Psoriasis

N/A
Waitlist Available
Led By Steve R Feldman, MD, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with psoriasis (ICD-9: 696.1)
Age 18-80
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial will study whether patients are more confident in the potential success of biologic medications in treating their psoriasis after being presented with clinical trial evidence, anecdotal evidence, or both.

Who is the study for?
This trial is for adults aged 18-80 with psoriasis who have never been treated with biologic medications. It aims to understand if different types of evidence can boost their confidence in using these drugs.Check my eligibility
What is being tested?
The study tests whether presenting patients with clinical trial evidence, anecdotal evidence, both, or no evidence affects their confidence in the success of biologic medications for treating psoriasis.See study design
What are the potential side effects?
Since this study focuses on patient perceptions rather than drug effects, it does not directly involve side effects. However, common side effects of biologics may include injection site reactions and increased risk of infections.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below
Select...
I have been diagnosed with psoriasis.
Select...
I am between 18 and 80 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Oral survey responses

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Anecdotal + Research Study EvidenceActive Control1 Intervention
Scenario describes a medication's (biologic's) therapeutic effect results based on research study evidence and anecdotal evidence.
Group II: Anecdotal EvidenceActive Control1 Intervention
Scenario describes a medication's (biologic's) therapeutic effect results based on anecdotal evidence.
Group III: Research Study EvidenceActive Control1 Intervention
Scenario describes a medication's (biologic's) therapeutic effect results based on research study evidence.
Group IV: No EvidencePlacebo Group1 Intervention
Scenario describes a medication's (biologic's) therapeutic effect with no mention on anecdotal nor research study evidence.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,231 Previous Clinical Trials
1,001,448 Total Patients Enrolled
12 Trials studying Psoriasis
603 Patients Enrolled for Psoriasis
Steve R Feldman, MD, PhDPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
210 Total Patients Enrolled
1 Trials studying Psoriasis
24 Patients Enrolled for Psoriasis

Media Library

Anecdotal + Research Study Evidence Clinical Trial Eligibility Overview. Trial Name: NCT03168347 β€” N/A
Psoriasis Research Study Groups: Anecdotal + Research Study Evidence, Anecdotal Evidence, Research Study Evidence, No Evidence
Psoriasis Clinical Trial 2023: Anecdotal + Research Study Evidence Highlights & Side Effects. Trial Name: NCT03168347 β€” N/A
Anecdotal + Research Study Evidence 2023 Treatment Timeline for Medical Study. Trial Name: NCT03168347 β€” N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the study consider applicants of all ages, or is there an upper age limit?

"The requisite age constraints for this clinical trial necessitate that the minimum enrolment age is 18 and the maximum is 80."

Answered by AI

What types of individuals are being sought for inclusion in this research?

"This medical trial seeks 300 individuals between 18 and 80 years old that have been diagnosed with psoriasis. To be considered, potential participants must meet the age requirement of being over 18 but under 81."

Answered by AI

How many participants are registered in this research program?

"Affirmative. Clinicaltrials.gov's data confirms that this medical trial was first posted on June 1st 2017 and is actively seeking qualified patients. The study requires 300 individuals to participate from a single location."

Answered by AI

Are any further participants needed for this investigation?

"Affirmative. According to records available on clinicaltrials.gov, this investigation is looking for 300 volunteers from 1 location and was first posted on June 1st 2017 with its most recent update occurring October 26th 2022."

Answered by AI
~10 spots leftby Jun 2024